NO20062398L - Daglig, oral, kontrollert frigivnings oksycodon-doserings form - Google Patents
Daglig, oral, kontrollert frigivnings oksycodon-doserings formInfo
- Publication number
- NO20062398L NO20062398L NO20062398A NO20062398A NO20062398L NO 20062398 L NO20062398 L NO 20062398L NO 20062398 A NO20062398 A NO 20062398A NO 20062398 A NO20062398 A NO 20062398A NO 20062398 L NO20062398 L NO 20062398L
- Authority
- NO
- Norway
- Prior art keywords
- profiles
- dosage form
- controlled release
- daily oral
- oral controlled
- Prior art date
Links
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 title abstract 2
- 239000002552 dosage form Substances 0.000 title abstract 2
- 229960002085 oxycodone Drugs 0.000 title abstract 2
- 238000013270 controlled release Methods 0.000 title 1
- 238000001727 in vivo Methods 0.000 abstract 3
- 230000002411 adverse Effects 0.000 abstract 1
- 230000002051 biphasic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51588003P | 2003-10-29 | 2003-10-29 | |
| PCT/US2004/036132 WO2005041968A2 (fr) | 2003-10-29 | 2004-10-28 | Formes posologiques orales d'oxycodone en dose quotidienne unique et a liberation controlee |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20062398L true NO20062398L (no) | 2006-07-27 |
Family
ID=34549453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20062398A NO20062398L (no) | 2003-10-29 | 2006-05-26 | Daglig, oral, kontrollert frigivnings oksycodon-doserings form |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1677798A2 (fr) |
| JP (1) | JP2007509979A (fr) |
| KR (1) | KR20060108690A (fr) |
| CN (1) | CN1933837A (fr) |
| AU (1) | AU2004285547A1 (fr) |
| BR (1) | BRPI0415639A (fr) |
| CA (1) | CA2546691A1 (fr) |
| EC (1) | ECSP066534A (fr) |
| IL (1) | IL175193A0 (fr) |
| MA (1) | MA28215A1 (fr) |
| NO (1) | NO20062398L (fr) |
| RU (1) | RU2006118323A (fr) |
| WO (1) | WO2005041968A2 (fr) |
| ZA (1) | ZA200604310B (fr) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2295043A1 (fr) | 1999-10-29 | 2011-03-16 | Euro-Celtique S.A. | Formulations d'hydrocodone à liberation lente |
| US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
| AU2002227383B2 (en) | 2000-10-30 | 2004-07-08 | Euro-Celtique S.A. | Controlled release hydrocodone formulations |
| UA81224C2 (uk) * | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
| US20110104214A1 (en) | 2004-04-15 | 2011-05-05 | Purdue Pharma L.P. | Once-a-day oxycodone formulations |
| US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
| DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
| US8075872B2 (en) | 2003-08-06 | 2011-12-13 | Gruenenthal Gmbh | Abuse-proofed dosage form |
| US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
| DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| DE102004032051A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform |
| DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| SA07280459B1 (ar) | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
| DE102007011485A1 (de) | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Darreichungsform mit erschwertem Missbrauch |
| TWI454288B (zh) | 2008-01-25 | 2014-10-01 | Gruenenthal Chemie | 藥物劑型 |
| JP2011511782A (ja) | 2008-02-12 | 2011-04-14 | アボット・ラボラトリーズ | 長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途 |
| ES2599031T3 (es) | 2008-05-09 | 2017-01-31 | Grünenthal GmbH | Proceso para la preparación de una formulación de polvo intermedia y una forma de dosificación solida final utilizando un paso de congelación por pulverización |
| BR112012001466A2 (pt) | 2009-07-22 | 2020-08-11 | Grünenthal GmbH | forma de dosagem resistente à falsificação para opioides sensíveis à oxidação, seu processo de fabricação, e embalagem |
| ES2534908T3 (es) | 2009-07-22 | 2015-04-30 | Grünenthal GmbH | Forma de dosificación de liberación controlada extruida por fusión en caliente |
| US20110150989A1 (en) * | 2009-12-22 | 2011-06-23 | Mallinkckrodt Inc. | Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans |
| US9884022B2 (en) * | 2010-04-07 | 2018-02-06 | Lupin Limited | Controlled release pharmaceutical compositions of tapentadol |
| WO2012028318A1 (fr) | 2010-09-02 | 2012-03-08 | Grünenthal GmbH | Forme pharmaceutique inviolable comportant un polymère anionique |
| CA2808219C (fr) | 2010-09-02 | 2019-05-14 | Gruenenthal Gmbh | Forme pharmaceutique inviolable comportant un sel inorganique |
| BR112014002022A2 (pt) | 2011-07-29 | 2017-02-21 | Gruenenthal Gmbh | comprimido resistente à violação proporcionando liberação de fármaco imediata |
| JP6063462B2 (ja) | 2011-07-29 | 2017-01-18 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 即時薬剤放出を提供するタンパーレジスタント錠剤 |
| BR112014019988A8 (pt) | 2012-02-28 | 2017-07-11 | Gruenenthal Gmbh | Forma de dosagem resistente a socamento compreendendo um composto farmacologicamente ativo e um polímero aniônico |
| LT2838512T (lt) | 2012-04-18 | 2018-11-12 | GrĆ¼nenthal GmbH | Pažeidimui atspari ir dozės atpalaidavimo nuokrypiui atspari farmacinė vaisto forma |
| US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
| AU2014273227B2 (en) | 2013-05-29 | 2019-08-15 | Grunenthal Gmbh | Tamper-resistant dosage form containing one or more particles |
| MX2015016254A (es) | 2013-05-29 | 2016-04-20 | Gruenenthal Gmbh | Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal. |
| AU2014289187B2 (en) | 2013-07-12 | 2019-07-11 | Grunenthal Gmbh | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer |
| HK1224189A1 (zh) | 2013-11-26 | 2017-08-18 | Grünenthal GmbH | 通过低温研磨制备粉状药物组合物 |
| WO2015173195A1 (fr) | 2014-05-12 | 2015-11-19 | Grünenthal GmbH | Formulation pour capsule à libération immédiate résistant aux manipulations illicites comprenant du tapentadol |
| US9872835B2 (en) | 2014-05-26 | 2018-01-23 | Grünenthal GmbH | Multiparticles safeguarded against ethanolic dose-dumping |
| WO2016170097A1 (fr) | 2015-04-24 | 2016-10-27 | Grünenthal GmbH | Forme galénique inviolable avec libération immédiate et résistance à l'extraction par solvant. |
| CA2998259A1 (fr) | 2015-09-10 | 2017-03-16 | Grunenthal Gmbh | Protection contre un surdosage par voie orale a l'aide de formulations a liberation immediate dissuasives d'abus |
| CN109789141B (zh) | 2016-08-10 | 2022-08-26 | 豪夫迈·罗氏有限公司 | 包含Akt蛋白激酶抑制剂的药物组合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5914131A (en) * | 1994-07-07 | 1999-06-22 | Alza Corporation | Hydromorphone therapy |
| UA81224C2 (uk) * | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
| MXPA04010769A (es) * | 2002-04-29 | 2005-07-05 | Alza Corp | Metodos y formas de dosificacion para suministro controlado de oxicodona. |
| CA2487786A1 (fr) * | 2002-05-31 | 2003-12-11 | Alza Corporation | Formes galeniques et compositions d'administration osmotique de diverses posologies de l'oxycodone |
-
2004
- 2004-10-28 KR KR1020067010336A patent/KR20060108690A/ko not_active Withdrawn
- 2004-10-28 RU RU2006118323/15A patent/RU2006118323A/ru unknown
- 2004-10-28 EP EP04817492A patent/EP1677798A2/fr not_active Withdrawn
- 2004-10-28 CA CA002546691A patent/CA2546691A1/fr not_active Abandoned
- 2004-10-28 AU AU2004285547A patent/AU2004285547A1/en not_active Abandoned
- 2004-10-28 BR BRPI0415639-0A patent/BRPI0415639A/pt not_active IP Right Cessation
- 2004-10-28 CN CNA2004800394188A patent/CN1933837A/zh active Pending
- 2004-10-28 WO PCT/US2004/036132 patent/WO2005041968A2/fr not_active Ceased
- 2004-10-28 JP JP2006538357A patent/JP2007509979A/ja not_active Withdrawn
-
2006
- 2006-04-25 IL IL175193A patent/IL175193A0/en unknown
- 2006-04-28 EC EC2006006534A patent/ECSP066534A/es unknown
- 2006-04-28 MA MA28979A patent/MA28215A1/fr unknown
- 2006-05-26 NO NO20062398A patent/NO20062398L/no not_active Application Discontinuation
- 2006-05-26 ZA ZA200604310A patent/ZA200604310B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004285547A1 (en) | 2005-05-12 |
| BRPI0415639A (pt) | 2006-12-12 |
| JP2007509979A (ja) | 2007-04-19 |
| EP1677798A2 (fr) | 2006-07-12 |
| CN1933837A (zh) | 2007-03-21 |
| RU2006118323A (ru) | 2007-12-10 |
| CA2546691A1 (fr) | 2005-05-12 |
| WO2005041968A3 (fr) | 2006-06-22 |
| KR20060108690A (ko) | 2006-10-18 |
| MA28215A1 (fr) | 2006-10-02 |
| WO2005041968A2 (fr) | 2005-05-12 |
| IL175193A0 (en) | 2008-04-13 |
| ZA200604310B (en) | 2007-11-28 |
| ECSP066534A (es) | 2006-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005041968A3 (fr) | Formes posologiques orales d'oxycodone en dose quotidienne unique et a liberation controlee | |
| GEP20125701B (en) | Application of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile | |
| CY1112478T1 (el) | Ενωσεις κιναζολινονης ως αντικαρκινικοι παραγοντες | |
| TW200718689A (en) | 2-Amino-quinazolin-5-ones | |
| MXPA05013142A (es) | Compuestos de piridinio [1,2-a]pirimidin-4-ona como agentes anticancer. | |
| NO20076613L (no) | Farmasoytiske formuleringer og anvendelse derav | |
| CA2683786C (fr) | Utilisation du tapentadol dans le traitement de la douleur et avec une incidence reduite d'effets secondaires induits par le tapentadol | |
| SG166093A1 (en) | Inhibitors of brutonæs tyrosine kinase | |
| MY147393A (en) | Administration of dipeptidyl peptidase inhibitors | |
| TW200630093A (en) | Dose forms | |
| TNSN08143A1 (en) | 2-amino-7,8-dihydro-6h-pyrido[4,3-d]pyrimidin-5-ones | |
| WO2006060507A3 (fr) | Procedes et compositions d'utilisation de composes immunomodulatoires pour le traitement des troubles d'immunodeficience | |
| NZ588913A (en) | Liver cancer drug | |
| WO2004006859A3 (fr) | Composes de platine | |
| HRP20050436A2 (en) | Quinolinyl-pyrrolopyrazoles | |
| TW200716628A (en) | Novel compounds | |
| TNSN07263A1 (en) | Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them | |
| BR0309620A (pt) | Métodos e formas de dosagem para liberação controlada de oxicodona | |
| NZ593199A (en) | Milnacipran for the long-term treatment of fybromyalgia syndrome | |
| MY133107A (en) | Use of pyrimidine derivatives for the prophylaxis and therapy of cerebral ischemia | |
| EP1503748A4 (fr) | Medicaments servant a attenuer la neurotoxicite induite par le taxane | |
| RU2007122391A (ru) | S-миртазапин для лечения приливов | |
| MX2010005009A (es) | Uso de compuestos inmunomoduladores para el tratamiento de trastornos asociados con disfunciones endoteliales. | |
| PL1718651T3 (pl) | Pochodne 7H-pirolopirymidyny | |
| TW200616951A (en) | Indole derivatives, their manufacture and use as pharmaceutial agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |